A detailed history of Barrett & Company, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Barrett & Company, Inc. holds 100 shares of ZTS stock, worth $16,484. This represents 0.01% of its overall portfolio holdings.

Number of Shares
100
Previous 261 61.69%
Holding current value
$16,484
Previous $45.2 Million 56.75%
% of portfolio
0.01%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$172.58 - $196.48 $27,785 - $31,633
-161 Reduced 61.69%
100 $19.5 Million
Q2 2024

Jul 25, 2024

BUY
$145.54 - $178.83 $145 - $178
1 Added 0.38%
261 $45.2 Million
Q2 2023

Jul 27, 2023

BUY
$160.94 - $186.23 $1,448 - $1,676
9 Added 3.59%
260 $44.8 Million
Q1 2023

May 11, 2023

BUY
$145.48 - $175.02 $36,515 - $43,930
251 New
251 $41.8 Million
Q4 2022

May 23, 2023

SELL
$131.14 - $157.47 $1,967 - $2,362
-15 Reduced 5.98%
236 $34.6 Million
Q3 2022

Jun 13, 2023

SELL
$148.29 - $182.55 $2,224 - $2,738
-15 Reduced 5.98%
236 $34.6 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Barrett & Company, Inc. Portfolio

Follow Barrett & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barrett & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Barrett & Company, Inc. with notifications on news.